Resources Contact Us Home
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/85.2
Name: Drug, bio-affecting and body treating compositions > Lymphokine > Interleukin
Description: Subject matter in which the immune mediator is a macrophage derived factor that promotes short term proliferation of T cells (IL1) or a lymphocyte derived factor that promotes long term proliferation of T cells in culture (IL2).

Patents under this class:

Patent Number Title Of Patent Date Issued
6680057 Methods of treating autoimmune disease by administering interleukin-17 receptor Jan. 20, 2004
6669934 Method of modulating fertility in animals by IL-11 Dec. 30, 2003
6669938 ImmunoConjucates for cancer diagnosis and therapy Dec. 30, 2003
6663859 Compositions for enhancing the immune response Dec. 16, 2003
6663878 Anti-inflammatory bioactive glass particulates Dec. 16, 2003
6660258 Oromucosal cytokine compositions and uses thereof Dec. 9, 2003
6656462 Interleukin-1 muteins useful as vaccine adjuvants Dec. 2, 2003
6645486 Method of treatment with IL-9 conjugate Nov. 11, 2003
6638517 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis Oct. 28, 2003
6632456 Compositions for inhalation Oct. 14, 2003
6630576 Amino acid substitution mutants of interleukin 13 Oct. 7, 2003
6623472 Method for inducing therapeutically-effective proteins Sep. 23, 2003
6623731 Compounds and compositions for delivering active agents Sep. 23, 2003
6620590 Diagnosis of pre-eclampsia Sep. 16, 2003
6613337 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis Sep. 2, 2003
6610286 Method for treating inflammation using soluble receptors to interleukin-20 Aug. 26, 2003
6605272 Methods of using zalpha11 ligand Aug. 12, 2003
6599501 Immunomodulators Jul. 29, 2003
6599509 Compositions and methods comprising helicobacter antigens for treatment and prevention of inflammatory bowel disease Jul. 29, 2003
6599875 IL-6 antagonist peptides Jul. 29, 2003
6593300 (3R)-3-amino-4-carboxybutyraldehyde derivatives inhibiting the release of interleukin-1/beta Jul. 15, 2003
6585957 Medicinal aerosol formulation Jul. 1, 2003
6586002 Enhanced circulation effector composition and method Jul. 1, 2003
6586400 Human therapeutic uses of BPI protein products Jul. 1, 2003
6582689 IL-18/IGIF chemotherapeutic compositions Jun. 24, 2003
6582690 Process for treating tumors with cytotoxic substances Jun. 24, 2003
6583270 Interleukin-19 Jun. 24, 2003
6579520 IL-17 related mammalian cytokine polypeptides (IL-17E) Jun. 17, 2003
6579521 Methods of therapy for HIV infection Jun. 17, 2003
6576231 Methods for treating HIV-Infected Patients by the Administration of GM-CSF and a protease inhibitor Jun. 10, 2003
6576232 IL13 mutants Jun. 10, 2003
6572852 Method for suppressing inflammatory responses by administering TNFR Jun. 3, 2003
6565842 Crosslinkable polypeptide compositions May. 20, 2003
6562333 Purified mammalian CTLA-8 antigens and related reagents May. 13, 2003
6562334 Canine interleukin 12 administration as an immune disease treatment May. 13, 2003
6562578 IL-17-like cytokine binding compounds and antibodies May. 13, 2003
6558660 Method for regulating IL-10 with IL-9, and applications thereof May. 6, 2003
6559133 Use of flavone 8-acetic acid in vascular and cardiovascular interventions and acute coronary syndromes May. 6, 2003
6548055 Immunologic enhancement with intermittent interleukin-2 therapy Apr. 15, 2003
6544504 Combined use of interleukin 10 and methotrexate for immuno-modulatory therapy Apr. 8, 2003
6540993 Method of treating inflammatory bowel disease using a topical formulation of IL-11 Apr. 1, 2003
6534050 2-methyl-3-butenyl-1-pyrophosphoric acid salts and agents for treating lymphocytes Mar. 18, 2003
6528051 Methods and compositions for enhancing immune response Mar. 4, 2003
6525020 Compounds and compositions for delivering active agents Feb. 25, 2003
6525102 Stabilized liquid polypeptide-containing pharmaceutical compositions Feb. 25, 2003
6509015 Human antibodies that bind human TNFa Jan. 21, 2003
6509313 Stimulation of immune response with low doses of cytokines Jan. 21, 2003
6509321 Treatment of Kaposi's sarcoma with IL-12 Jan. 21, 2003
6506582 Processed polypeptides with IL-16 activity, process for preparing the same and their use Jan. 14, 2003
6500417 Mutants of human interleukin-3 Dec. 31, 2002

  Recently Added Patents
Composite conductive pads/plugs for surface-applied nerve-muscle electrical stimulation
Battery pack with connecting device
Antitumoral compounds
System, method and computer program product for monitoring and controlling network connections from a supervisory operating system
Method for producing carrier on which microorganisms capable of conducting multiple parallel mineralization are immobilized, column reactor and solid medium for cultivating plants
Coreference resolution in an ambiguity-sensitive natural language processing system
Decoration holder
  Randomly Featured Patents
Chemical vapor deposition apparatus having cooling heads adjacent to gas dispersing heads in a single chamber
Eddy current position indicating apparatus for measuring displacements of core components of a liquid metal nuclear reactor
Method of assembling a door
DFB semiconductor laser device having ununiform arrangement of a diffraction grating
Data storage systems
Fast text/graphics resolution improvement with chain-code table look-up
Surface for a seat of a cycle
Injector for implanting a folded intraocular lens, container for storing and transporting the injector and method for ejecting the lens in a folded state
Hertzian-wave intrusion detetor
Reverse-mode direct-view display employing a liquid crystal having a characteristic wavelength in the non-visible spectrum